J. Loumeau Eric's most recent trade in AnaptysBio Inc was a trade of 67,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 67,000 | 67,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 23,550 | 23,550 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 7,288 | 21,862 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 7,288 | 10,669 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 5,545 | 11,090 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 5,545 | 13,220 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.60 per share. | 03 Jan 2025 | 2,994 | 7,675 (0%) | 0% | 14.6 | 43,712 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 03 Jan 2025 | 2,217 | 11,003 (0%) | 0% | 15.3 | 33,920 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.13 per share. | 14 Sep 2024 | 6,500 | 7,020 (0%) | 0% | 40.1 | 260,845 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 6,000 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 6,000 | 10,740 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.02 per share. | 14 Sep 2024 | 5,000 | 13,520 (0%) | 0% | 14.0 | 70,100 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 5,000 | 73,000 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.41 per share. | 14 Sep 2024 | 3,780 | 3,240 (0%) | 0% | 38.4 | 145,191 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.93 per share. | 14 Sep 2024 | 2,220 | 8,520 (0%) | 0% | 38.9 | 86,425 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2024 | 20,000 | 20,000 | - | - | Common Stock | |
| AnaptysBio Inc | J. Loumeau Eric | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 16 Feb 2024 | 5,000 | 3,240 (0%) | 0% | 25 | 125,000 | Common Stock |
| AnaptysBio Inc | Loumeau Eric J. | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.02 per share. | 16 Feb 2024 | 5,000 | 8,240 (0%) | 0% | 14.0 | 70,100 | Common Stock |
| AnaptysBio Inc | Loumeau Eric J. | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 5,000 | 78,000 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | J. Loumeau Eric | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 5,545 | 16,635 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Eric Loumeau J. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 5,545 | 5,545 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Eric Loumeau J. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.81 per share. | 06 Jan 2024 | 2,305 | 3,240 (0%) | 0% | 21.8 | 50,272 | Common Stock |
| AnaptysBio Inc | J. Eric Loumeau | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 79,780 | 79,780 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | J. Eric Loumeau | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 29,150 | 29,150 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 60,530 | 60,530 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 22,180 | 22,180 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 08 Aug 2022 | 523 | 0 (0%) | 0% | 25 | 13,075 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 08 Jun 2022 | 2,500 | 523 (0%) | 0% | 24 | 60,000 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 2,500 | 83,000 | - | - | Employee Stock Option (Right to Buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.02 per share. | 08 Jun 2022 | 2,500 | 3,023 (0%) | 0% | 14.0 | 35,050 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Sale of securities on an exchange or to another person at price $ 20.50 per share. | 18 May 2022 | 1,146 | 523 (0%) | 0% | 20.5 | 23,493 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 22.03 per share. | 15 Nov 2021 | 523 | 523 (0%) | 0% | 22.0 | 11,522 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 04 Nov 2021 | 5,000 | 0 (0%) | 0% | 35 | 175,000 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.16 per share. | 04 Nov 2021 | 2,500 | 5,000 (0%) | 0% | 20.2 | 50,400 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 2,500 | 7,500 | - | - | Employee Stock Option (Right to Buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 2,500 | 85,500 | - | - | Employee Stock Option (Right to Buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.02 per share. | 04 Nov 2021 | 2,500 | 2,500 (0%) | 0% | 14.0 | 35,050 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 10 Feb 2021 | 10,000 | 0 (0%) | 0% | 35 | 350,000 | Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 10,000 | 88,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.02 per share. | 10 Feb 2021 | 10,000 | 10,000 (0%) | 0% | 14.0 | 140,200 | Common Stock |